CureBay Secures Rs 100 Crore for Rural Healthcare Expansion
CureBay, a rural healthcare startup, has successfully raised approximately Rs 100 crore in a Pre-Series C funding round that is led by IvyCap Ventures. This funding round includes Rs 69 crore in equity coming from IvyCap Ventures along with additional contributions from existing investors. Moreover, more than Rs 30 crore in debt financing has been secured from Trifecta Capital, Alteria Capital, and VentureSoul Partners. The company aims to utilise the funds to broaden its reach throughout India, including a significant entry into Andhra Pradesh. Additionally, CureBay plans to enhance its technological and artificial intelligence capabilities to improve health screening, patient insights, and clinical decision-making.
CureBay Overview
Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Swain, CureBay operates a network of technology-enabled clinics, catering to healthcare needs in underserved regions. The range of services provided includes doctor consultations, medications, diagnostic tests, surgery facilitation, and annual health memberships.
Expansion and Impact
Currently, the company manages over 250 clinics spread across seven states, supported by a workforce of more than 1,800 Swasthya Mitras, 530 trained clinical staff, 230 doctor partners, and over 210 partner hospitals and laboratories. CureBay has already served more than 17 lakh patients and conducts over 400 health camps every month.
Healthcare System
CureBay implements a six-layer rural healthcare system that integrates physical clinics, a community health worker network, a digital platform, AI-powered screening, a 24/7 command centre, and CureBay Kavach. The company collaborates with government initiatives on healthcare delivery and has been designated as the healthcare partner for Samriddhi Kendra, a noteworthy Government of India initiative.
Recent Funding Achievements
In May 2025, CureBay successfully raised $21 million during a Series B round led by Bertelsmann India Investments. This round also featured participation from existing investor Elevar Equity and British International Investment.